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Abstract: The misuse of antibiotics in humans, animals, and plants is related to the spread of resistant
antibiotic strains among humans and animals. In this paper, we carry out a bibliographic search
of Medline, Web of Knowledge, and Cab Abstracts with the main objective of ascertaining the
available evidence on non-clinical factors and attitudes that could influence the prescription of
antibiotics by veterinarians. A total of 34 studies fulfilled the inclusion criteria. Whereas, veterinary
health professionals’ prescribing habits did not appear to be influenced by their socio-demographic
characteristics, they were influenced by different attitudes, such as fear (identified in 19 out of
34 studies), self-confidence (19/34), business factors (19/34), and by complacency (16/34). Certain
owner-related factors, such as lack of awareness (16/34) and demand for antibiotics (12/34), were
also important, as were concurrent factors, ranging from a lack of appropriate regulations (10/34) to
the expense and delays involved in performing culture and sensitivity tests (10/34) and inadequate
farm hygiene (8/34). Our results appear to indicate that the non-clinical factors are potentially
modifiable. This may be useful for designing interventions targeted at improving antibiotic use in
animals, as part of an overall strategy to reduce the global spread of multi-resistant strains.
Keywords: veterinarians; antibiotic resistance; antibiotic prescription; one health; animal health;
infection control; antibiotic stewardship
1. Introduction
Antimicrobials are a key resource, and antimicrobial resistance is acknowledged as
one of the most serious threats currently facing public health worldwide. The problem
of resistance does not only affect human medicine. In addition, while the transfer of
resistance between animals and humans continues to be the subject of research, many
studies published in recent years nonetheless show that antibiotic (ABX) use in animals
can contribute to the appearance of resistant pathogens in animals and humans alike [1–7].
The amount of antibiotics consumed by animals worldwide is huge, according to some
estimates and if measures are not taken, this use will continue to rise around the world,
with estimates showing that by 2030 it will be 11.5% higher than in 2017 [8]. Although,
it is important to highlight the differences between low and middle-income countries [9]
and North America and Europe, where, for the 25 countries reporting sales data to the
ESVAC for each year from 2011 to 2017, an overall decrease of 32.5% in sales (mg/PCU)
was observed [10]. On the other hand, the use of antimicrobial preparations designed
for groups of animals (pre-mixes, oral powders, and oral solutions) continues to be a
common practice [10,11]. This mass treatment of animals increases the likelihood of sick
and healthy animals being exposed -repeatedly in many instances- to subtherapeutic
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doses of broad-spectrum ABXs [11], which could further increase the risk of generating
resistance [12–15].
Even though the most recent research concludes that the use of antibiotics in animals
contributes to the human antimicrobial burden by only a small degree [16], a recent meta-
analysis concludes that interventions which restrict antibiotic use in animals may reduce
the prevalence of resistant bacteria in humans [5]. Based on this fact, the latest World
Health Organization (WHO) guidelines firmly recommend a general reduction in the
use of critically important antimicrobials for human health in animal production [17]. In
parallel to this, the OIE (World Organization for Animal Health) has also developed a list
of antimicrobials which are of critical importance in veterinary medicine, the use of which
should be restricted [18]. It is important to reduce antibiotic use in all sectors and to ensure
that antibiotics remain effective as long as possible The WHO and European Union (EU)
urge Member States to develop and implement strategies to contain the development of
antibiotic resistance from a joint human, plant, and veterinary perspective, the so-called
“One Health approach”, a collaborative, multisectoral, and transdisciplinary approach with
the goal of achieving optimal health outcomes recognizing the interconnection between
people, animals, plants, and their shared environment [19,20].
In the development and implementation of these strategies, physicians, patients,
pharmacists, and veterinarians all play a key role. Identification of the non-clinical factors
associated with the prescription of ABXs in animals is an essential step towards being
able to implement effective interventions to improve ABX use in animals, and thereby
slow the expansion of multi-drug resistant microorganisms worldwide. These factors have
already been described in the case of physicians [21,22] and pharmacists [23] and it has been
demonstrated that they can influence the use of antibiotics by these professionals, but to
our knowledge there is no systematic review that identifies them in veterinarians. Despite
being completely different sectors, we consider that, as occurs in human medicine, there
may be factors other than clinical semiology itself affecting the prescription of antibiotics
in veterinary medicine. Therefore, our designated aim was to conduct a systematic review
to identify those factors and attitudes which do not form a part of clinical semiology or
are the direct result of complementary tests, but which might influence the prescribing
behavior on the part of veterinarians.
2. Results
2.1. Search Results
A total of 1386 papers were found in Medline, 1166 in Web of Knowledge, and 3209
in Commonwealth Agricultural Bureaux (CAB) Abstracts. The elimination of duplicates
yielded 4570 studies. After reading the abstracts, 117 were selected as potentially valid,
with 15 more papers being added on the basis of a review of the references cited in the
original studies. Finally, after an in-depth reading of the full text, 34 studies were included
in this review (see Figure 1. Flow chart).
2.2. Study Quality
All the studies of a quantitative or mixed nature complied with most of the criteria in
the AXIS tool [24], and were thus deemed eligible for inclusion in our review. Whereas, 75%
complied with almost all the items and were therefore deemed to display high methodolog-
ical quality and low susceptibility to bias. The remainder complied with 16 to 17 items and
were therefore considered to have a medium level of methodological quality (see Table S1
in the Supplementary Material).
As shown in Table S2, all the qualitative studies selected complied with the criteria
contained in the CASP tool (exploratory questions 1 and 2 in the chart) [25], and in the
remaining exploratory questions posed by the test.
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Figure 1. Flow chart.
2.3. Characteristics of the Selected Studies
The general characteristics of the studies selected are summarized in Table 1.
Of the selected studies, nineteen were of a quantitative nature, fourteen of a quali-
tative nature, and one contained an analysis of both types. All were observational cross-
sectional studies.
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Twenty-two studies focused on industrial animal production and six on pets, whereas
the other six were not confined to any specific sector.
Of the studies conducted in the industrial animal production, five were exclusively
devoted to milk yielding, five to the pig industry, and one to beef production. The remaining
studies did not target any specific area of production.
In terms of pathology, four of the studies undertaken in dairy farming focused on
udder health, and one focused on the prescription of ABXs against pig intestinal diseases.
The rest of the studies did not limit their research to any specific clinical condition.
Most of the studies were from Europe, four from Oceania, three from Asia, two from
America, and one from Africa.
Lastly, with respect to the methods used for data collection, most of the studies used
semi-structured postal/e-mail questionnaires, face-to-face interviews, or focus discus-
sion groups.
2.4. Factors Identified by the Selected Studies as Exerting an Influence
Each of the studies selected was examined to identify the non-clinical factors that
might influence antibiotic prescribing by veterinarians. To facilitate classification, these
factors were divided into two major blocks, intrinsic and extrinsic.
2.5. Intrinsic Factors
The factors intrinsic to professional veterinarians (summarized in Table 2) were further
subdivided into socio-demographic characteristics, attitudes, etc.
2.5.1. Socio-Demographic Characteristics
Among the studies of a quantitative nature, 10 evaluated the socio-demographic char-
acteristics of veterinarians in relation to antibiotic prescribing. Gender did not prove statis-
tically significant in four [31,35,37,40] out of the five studies [39], in which it was evaluated,
with similar results being reported for age (three significant/four evaluated) [31,37,39,40]
and professional status (3/5) [31,37,39,43,44]. In terms of professional experience, the
results were inconclusive: While two studies observed greater professional experience to
be an influence that apparently favored prescribing [39,40], one found the contrary [35],
and four further studies reported that it was not a significant factor [31,36,41,43].
Professional training was evaluated by only two studies [35,40], without conclusive
results being obtained.
2.5.2. Attitudes
Most (31) of the studies in this review reported that certain attitudes displayed by
veterinarians influenced their decision to prescribe antimicrobials.
Fear of possible complications in the animal(s) as a result of not administering an-
tibiotics was identified in eight quantitative studies [29,31–33,35,38,43], one of which
objectively established a statistically significant relationship [42], and was cited as influ-
ential by eleven further qualitative studies [45,47–53,55–57]. Fear of losing customers as
a result of failing to prescribe antibiotics was cited as having an influence by as many
as nine studies [39,45–47,49,53,56,58,59], though in another study that used the statistical
hypothesis test to evaluate the relationship, this did not prove significant [31].
Business factors were cited by nineteen studies [45–50,52–54,56,58,59], seven of which
were of a quantitative nature [27,38,39,41–44]. In another study, statistical hypothesis
testing failed to detect a relationship [40].
The confidence of veterinarians in their own prescribing habits, based on their prior
experience, was highlighted as a significant factor when deciding whether to use antibiotics
in 19 of the studies [26,28,29,32,33,35,36,39,42,43,46–49,52,53,56–58].
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Table 1. Methodological characteristics of the papers selected.
Author Year Country a StudyPopulation b Veterinary Practice Type N
c % R d Disease Data-Collection e
Quantitative
Eriksen [26] 2019 Denmark veterinarians livestock (swine) 105 83 Intestinal diseases Q
Hopman [27] 2019 Netherlands veterinarians small companion animal 350 22 Q
Doidge [28] 2019 UK veterinarians livestock 306 24 Q
Norris [29] 2019 Australia veterinarians multiple 403 4 Q
Carmo [30] 2018 EU veterinarians livestock 67 - Q
Scherpenzeel [31] 2018 Netherlands veterinarians livestock (dairy cattle) 181 28 Udder health Q
Coyne [32] 2018 UK surgeons veterinarians livestock (swine) 61 34 Q
Zhuo [33] 2018 Australia mixed multiple 403 4 Q
Kumar [34] 2018 India veterinarians livestock 48 - Q
Ekakoro [35] 2018 USA veterinarians multiple 62 51 Q
Barbarossa [36] 2017 Italy veterinarians small companion animal 266 12 Q
Anyanwu [37] 2017 Nigeria vet livestock 280 76 Q
Postma [38] 2016 EU veterinarians livestock 728 33 Q
Mc Dougall [39] 2016 New Zealand mixed livestock (dairy cattle) 206 34 Udder health Q
Visschers [40] 2015 EU mixed livestock (swine) 334 - Q
Speksnijder [41] 2015 Netherlands vet livestock 377 34 Q
De Briyne [42] 2013 EU veterinarians multiple 3004 1,5 Q
Gibbons [43] 2012 Ireland veterinarians livestock (cattle) 118 66 Q
Hughes [44] 2011 UK veterinarians small companion animal 460 51 Q
Qualitative
Golding [45] 2019 UK mixed livestock 13 - Telephone interview
Pucken [46] 2019 Switzerland veterinarians livestock (dairy cattle) 23 - Udder health FG
Hopman [47] 2018 Netherlands veterinarians multiple 18 72 Face to face
Smith [48] 2018 UK veterinarians small companion animal 16 - Face to face
King [49] 2018 UK surgeons veterinarians small companion animal 16 - Face to face
Chauhan [50] 2018 India mixed livestock 9 - Face to face
OM [51] 2017 Cambodia mixed livestock 9 - Face to face
Higgins [52] 2016 UK veterinarians livestock (dairy cattle) 20 100 Udder health Face to face
Coyne [53] 2016 UK surgeons veterinarians livestock (swine) 21 - Face to face
Etienne [54] 2016 EU mixed livestock 30 16 Face to face
Coyne [55] 2014 UK veterinarians livestock (swine) 9 - FG
Speksnijder [56] 2014 Netherlands veterinarians livestock 11 88 Face to face
Redding [59] 2014 Peru mixed livestock (dairy cattle) 12 - FG
Mateus [57] 2014 UK veterinarians small companion animal 21 - Face to face
Mixed
Hardefeldt [58] 2018 Australia veterinarians multiple 184 - Q Q
a Country: EU: Two or more countries of the European Union; UK: United Kingdom. b Study population: Mixed, several study populations, only veterinary results were collected. c Sample size: Number of
veterinarians that were included in the study. d Percentage response: Percentage of veterinarians on whom the study could be successfully carried out. -: Unknown. e Data collection: Q: Questionnaire; FG: Focus
group; Face-to-face: Qualitative face-to-face interview of a semi structured nature.
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Table 2. Intrinsic factors identified as influencing antibiotic prescription by veterinarians.
Author
Socio-Demographic Characteristics a Attitudes b
Others






Eriksen [26] C Advice fromcolleagues
Hopman [27] BF
Doidge [28] <30 ↑ CO ↑ C ↑ vet practice type(farm)↑
Norris [29] F1 RO C
Carmo [30]
Scherpenzeel [31] A ∼= G ∼= PS ∼= E ∼= F1 Region ∼=
Coyne [32] CO F1 C
Zhuo [33] F1 RO C
Kumar [34]
Ekakoro [35] G ∼= >E ↓ T∼= F1 C Veterinary practicetype ∼=
Barbarossa [36] E ∼= C
Anyanwu [37] A ∼= G ∼= PS ∼= I
Postma [38] F1 BF
Mc Dougall [39] Male↑ Owner ↑ >E ↑ CO F2 BF C
Visschers [40] A ∼= ∼= >E ↑ T↑ F1 ↑ F2 ∼= BF ∼= Country ∼=
Speksnijder [41] E ∼= RO BF
De Briyne [42] BF C practice type(equine) ↓
Gibbons [43] PS ∼= E ∼= CO F1 C Country ∼=
Hughes [44] Locums ↑ CO BF
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Table 2. Cont.
Author
Socio-Demographic Characteristics a Attitudes b
Others






Golding [45] CO F1 F2 RO BF
Pucken [46] F2 BF C
Hopman [47] Old CO F1 F2 RO BE C ID
Smith [48] young CO F1 BF C ID
King [49] CO F1 F2 BF C ID
Chauhan [50] CO F1 RO BF
OM [51] I F1 ID
Higgins [52] <E CO F1 RO BF C ID
Coyne [53] CO F1 F2 RO BF C Peer Pressure
Etienne [54] RO BF
Coyne [53] F1 RO
Speksnijder [56] CO F1 F2 RO BF C
Redding [59] CO F2 BF
Mateus [57] CO F1 C ID Peer Pressure
Mixed
Hardefeld [58] CO F2 RO BF C ID One vet in practice
Statistical significance (only quantitative studies). ∼=: This factor was not statistically significant; ↑: This factor leads to a statistically significant increase in antibiotic prescription; ↓: This factor leads to a
statistically significant decrease in antibiotic prescription; No symbol: In the reviewed article, this factor was associated with prescription, but there was no hypothesis testing. a Socio-demographic characteristics:
A: Age; G: Gender; PS: Professional status; E: Years of professional experience; T: Professional training courses; b Attitudes: I: Ignorance (lack of knowledge); C: Complacency; F: Fear; RO: Responsibility of others;
BF: Business factors; CF: Confidence in previous experience and habits; ID: Indifference.
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In 19 of the studies, we have identified that there could be complacency on the part of
veterinarians with the expectations that they believe their clients have, and that this can have
an influence when prescribing an antibiotic treatment [28,32,39,43–45,47–50,52,53,56–59].
Three quantitative studies [29,33,41] pinpointed the responsibility of other professional
groups, such as physicians or pharmacists, as being the main cause of the spread of
resistant strains. This was also described as a decisive factor by eight further studies of a
qualitative [45,47,50,53–56] nature and one of a mixed nature [58].
Indifference was identified in seven studies [47–49,51,52,57,58].
Finally, the lack of appropriate knowledge of prescribing and antibiotic resistance was
only mentioned by two studies [37,51].
2.5.3. Other Intrinsic Factors
In studies that straddled more than one territory, veterinarians’ country, region, or
origin did not seem to modify their intentions regarding prescribing [31,40,43]. However,
this refers to several countries in the same area.
Three studies highlighted the fact that pressure exerted by more experienced col-
leagues could facilitate or decrease the prescription of ABXs [28,53,57], and one found
that colleagues’ recommendations were a decisive influence when it came to the choice of
antibiotic [26].
2.6. Extrinsic Factors
The extrinsic factors of the studies selected are summarized in Table 3. These were
further subdivided into four sections:
2.6.1. Customer-Related Factors (Farmer/Pet Owner)
As many as 16 studies reported that customers’ lack of knowledge and indifference
to ABX use as well as the generation of resistance were factors that could boost ABX
prescribing [27,29,32,35,41,45,46,48,50–56,59]. Connected with this, the high demand for
antibiotics by customers was cited in 12 studies [34,37,39,41,43,47,48,53,55–58]. Addition-
ally, in 12 other studies, veterinarians argued that customers’ lack of training in how to
administer certain antibiotic guidelines or alternative therapies could properly compromise
their decisions [38,39,43,45,47,48,52–54,56,57,59].
2.6.2. Structural and Concurrent Factors
Grouped below are all the factors that determine the specific conditions under which
veterinarians work at any given point in time.
In eight of the studies, the presence of inadequate hygiene and biosafety conditions
on farms and agricultural holdings was highlighted as a factor that increased animals’
need for antibiotics [26,38,50–52,54–56]. For example, the lack of a suitable isolation circuit
for sick animals or inadequate climatization systems. It should be highlighted that these
types of factors were stressed by veterinarians working in the livestock sector, not by those
working with household pets.
Many veterinarians also cited the lack of time for examining animals properly and the low
number of veterinarians per clinic as factors that influenced treatment decisions [28,29,47,57,58].
Two studies evaluated whether having two or more veterinarians per clinic served to improve
antibiotic prescribing, without significant results being obtained [31,43].
Three studies underscored the fact that the pharmaceutical industry can alter veteri-
narians’ antibiotic prescribing in different ways [34,44,48].
Many studies singled out the long time [26,29,30,39,42,45,47,56] and high price [33,38,42,50,56,59]
involved in obtaining the results of culture and antibiogram sensitivity tests as important
bars to the judicious prescription of ABXs.
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Table 3. Extrinsic factors identified as influencing antibiotic prescription by veterinarians.
Author
Client a Structural b Antibiotic c Animal d
Others
LK/A LT HD BS TP PI PCT DCT LR AA AC Dosage WP I AB
Quantitative
Eriksen [26] BS LR AC Dosage
Hopman [27] LK/A
Doidge [28] TP ↑ Economic problems client ↑
Norris [29] LK/A TP PCT DCT AC Dosage Unclear prescription guidelines
Carmo [30] DCT Digestive and respiratory diseases
Scherpenzeel [31] No. of vets in practice ∼=
Coyne [32] LK/A
Zhuo [33]
Kumar [34] HD PI LR AA AC WP
Ekakoro [35] LK/A AA Dosage
Barbarossa [36] AC Dosage
Anyanwu [37] HD
Postma [38] LT BS AC WP I
Mc Dougall [39] LT HD DCT LR WP
Visschers [40] Good relationship with clients ↓
Speksnijder [41] LK/A HD
De Briyne [42] PCT DCT LR ↑ Dosage WP∼=
Gibbons [45] LT HD AC Dosage WP No. of vets in practice ∼=
Hughes [44] PI ↑ Dosage Referral hospital ↓/Acredited Hospital ↑
Qualitative
Golding [45] LK/A LT DCT WP I Client’s Personality
Pucken [46] LK/A LR I
Hopman [47] LT HD TP DCT LR AA AC Dosage AB
Smith [48] LK/A LT HD PI PCT DCT AA
King [49]
Chauhan [50] LK/A BS LR AA Not enough veterinarians
OM [51] LK/A BS LR Lack of surveillance systems
Higgins [52] LK/A LT BS
Coyne [55] LK/A LT HD AA
Etienne [54] LK/A LT BS Cultural barriers
Coyne [55] LK/A HD BS AA AC WP I Unprofessionalism
Speksnijder [56] LK/A LT HD BS PCT DCT LR I
Redding [59] LK/A LT AA Different antibiotic packaging
Mateus [57] LT HD TP PCT AA Dosage AB Economic problems client
Mixed
Hardefeldt [58] HD TP PCT LR
Statistical significance (only quantitative studies) ∼=: This factor was not statistically significant; ↑: This factor leads to a statistically significant increase in antibiotic prescription; ↓: This factor leads to a
statistically significant decrease in antibiotic prescription; no symbol: In the reviewed article, this factor was associated with prescription, but there was no hypothesis testing. a Client-related factors: LK/A:
Lack of knowledge or awareness; LA: Lack of training; HD: High client demand. b Structural: BS: Defects in biosecurity or hygiene on the farm; TP: Time pressure; PI: Pharmaceutical industry; PCT: Price of
culture tests and sensitivity; DCT: Delay of culture tests and sensitivity; LR: Lack of regulation in antibiotic policy. c Antibiotic: AA: Antibiotics availability; AC: Antibiotic cost; D: Available antibiotic dosage;
WP: Withdrawal period. d Animal characteristics: I: Immunity, understood as a defense mechanism against infection; AB: Animal behavior.
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With respect to antibiotic policy, four studies reported that the restrictions imposed
by the health authorities in different European countries on the administration of certain
antibiotics to animals served to reduce ABX misuse [26,42,46,47]. Furthermore, the absence
of animal-centered ABX prescription policies was mentioned by six other studies as a factor
that facilitated inappropriate prescribing [34,39,50,51,56,58].
Prescription guidelines were perceived as positive by almost all veterinarians, but
their lack of clarity was highlighted by one study [29].
2.6.3. Antibiotic-Related Factors
Nine studies indicated that antibiotic prescribing was often influenced by the unavail-
ability of appropriate antimicrobials or the impossibility of applying different therapeutic
alternatives to an antimicrobial treatment (due to the lack of material, time, or train-
ing) [34,35,47,48,50,53,55,57,59]. The cost of some ABXs was also perceived as a bar by
eight other studies [26,29,34,36,38,43,47,55]. These limitations can make veterinarians lean
towards higher importance antimicrobials than recommended in the guidelines.
A number of studies reported that, aside from their spectrum of action, certain charac-
teristics of the antimicrobials available on the market exert an influence when it comes to
choosing a treatment.
Up to nine studies concluded that the dosage and form of administration [26,29,35,36,42–44,47,57]
of the available antimicrobials are decisive factors when deciding what to prescribe. There-
fore, making antimicrobials which require subcutaneous injections and fewer doses, the
preferred choice of many veterinarians: One example of this is cefovecin, an antibiotic
chosen to treat a large number of cat and dog diseases due to its subcutaneous route of
administration and just one injection in most cases.
Another aspect linked to the characteristics of antibiotics available in the veterinary
sector is what is known as the withdrawal (or withholding) period. This is the mandatory
time which must elapse between the last application of an antibiotic and use of animal-
based products and is aimed at ensuring that there are no antibiotic residues in these
products or that they lie within the permitted limits for the medication and foodstuff in
question. This period varies, depending on the antibiotic and the livestock species in
which it is used, the animal product to be used, and the jurisdiction and consequences for
non-compliance are severe. This factor was cited by veterinarians as fundamental in as
many as six studies [34,38,39,43,45,55].
2.6.4. Animal-Related Factors
The clinical profiles exhibited by animals (signs, results of complementary tests, etc.),
are the most influential animal-related factors, when it came to deciding whether or not
an antibiotic was to be prescribed, did not come within this review’s designated scope of
analysis.
Clinical aspects aside, few animal-related factors were identified. In five studies [38,45,46,55,56],
veterinarians maintained that animals produced by intensive animal breeding displayed
a weak immune system, which rendered them more vulnerable to infections and, by ex-
tension, to receiving anti-biotherapy. In two other studies [47,57], veterinarians stated that
the animal’s behavior, especially if aggressive, could modify the treatment decision by
favoring the administration of broad-spectrum injectable antibiotics or oral medication if it
is not possible to approach the animal.
The remaining factors mentioned in the studies were cited by few papers or yielded
widely varying results.
3. Discussion
To our knowledge, this is the first review to analyze the various factors, other than
purely clinical aspects, that can influence veterinarians when it comes to prescribing antibi-
otics. Different attitudes of veterinarians, such as fear, self-confidence, and complacency,
can influence prescribing, as can extrinsic factors, ranging from poor or non-existent cus-
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tomer awareness with antibiotic stewardship to inadequate farm hygiene and lack of
regulation, along with certain characteristics of available ABXs, such as being cheap or
easy to administer, and the rapidity and cost of culture and sensitivity tests. Many of
these factors are potentially modifiable and could well be the focus of future interventions
targeted at improving ABX use in animals.
3.1. Socio-Demographic Factors
It appears that neither the veterinarians’ gender, age, nor professional status influences
prescribing. The only socio-demographic characteristic that seems to exert an influence is
professional experience: A number of studies suggested that less experienced veterinarians
could favor more ABX prescribing, partly due to the fact that they lack confidence in
their diagnostic skills and are thus more vulnerable to the opinions of third-parties such
as clients. Clinical practice protocols and prescription guidelines can help veterinarians
acquire greater confidence [37,41,42,48,53,57,58]. Indeed, veterinarians who make use of
prescription guidelines, scientific literature, and the advice of specialists are less inclined
to prescribe incorrect dosages than those who do not use these data sources [44]. Other
studies, in contrast, indicated that it is the most experienced veterinarians who have a
greater tendency to prescribe antibiotics: This may be due to the fact that their years of
training lie in the past, at a time when far less stress was laid on the prudent use of ABXs.
Consequently, even veterinarians with decades of experience could benefit from refresher
courses to update them on the subject [30,39,57,58]. Even so, recent studies report a
substantial variation in compliance with treatment guidelines or accepted standards among
Australian veterinarians, depending on the species treated and the clinical circumstances.
These same studies also show that socio-demographic characteristics do not influence
compliance with guidelines, and the results are similarly contradictory with respect to
veterinarians’ year of graduation [60–63]. No relationship has been found between these
results and the region or professional sector in which the study was contextualized.
3.2. Attitudes
Some of the veterinarians’ attitudes do indeed appear to influence prescribing, such as
confidence in their own decisions, influenced by their habits and previous experiences. Previ-
ous experience is a useful tool when taking decisions but the excess of trust in customs and
experience may act as a barrier to correct prescribing and hinder the incorporation of new in-
formation. To minimize this, among other measures, we believe it is important to ensure access
to up-to-date scientific information through continuing education [30,33,43,44,47,49,50,58],
whether via face-to-face courses or by taking advantage of currently available digital re-
sources, with an emphasis at all times on the importance of prudent ABX use and the negative
consequences of misprescription [42,54,56,57]. It would also be useful to implement clinical
decision-support systems to increase these practitioners’ confidence [28].
Many studies make the point that both veterinarians’ explicit and implicit client ex-
pectations of antibiotics can lead to misprescription, something that has also been reported
by physicians and pharmacists [22,23]. For example, some veterinarians stated that they
felt their customers expected something tangible from a consultation, in the form of medi-
cation [48]. Therefore, veterinarians must be empowered by the health authorities, in order
to ensure that they feel responsible for taking the lead in the rational use of ABXs, and that
this criterion prevails over external pressures [48,57].
Many veterinarians fear the possible negative consequences of not prescribing ABXs
for an animal’s wellbeing at a given point in time. This same fear has been shown to be
decisive in prescribing decisions in the sphere of human medicine [21,23]. The perception
of risk and diagnostic uncertainty is a known driver of human behavior [64,65].
In order to reduce dependence on antibiotics and to avoid the consequences which
a selection of resistant strains may have for individual animals or for a farm as a whole,
preventive measures are essential [38,39,41,56], for example, good management, good
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feeding, regular veterinary controls to ensure vaccination and parasite treatments, good
internal and external biosecurity, etc. [32,36,39,49,53,55,57].
Sight should not be lost on the fact that veterinary practice is often framed within
the activities of the private sector, in which veterinarians acknowledge how different
business factors, such as customers’ economic possibilities [51,57], the price of preventive
interventions or alternative therapies [54], indirect costs, market tensions, competition [59],
etc., can influence their prescribing. However, we never perceive the quest for personal
economic benefit. Likewise, and closely linked to the above factors, the fear of losing
a customer as a result of not dispensing an ABX (something that also happens with
pharmacists [23]), was also highlighted [56,59].
It has also been suggested that there is a conflict of interest between correct pre-
scribing and the profit that veterinarians themselves can obtain from the direct sale of
ABXs [44,53]. For this reason, it has been proposed that prescribing be “decoupled” from
dispensing [66]. However, the majority of veterinarians reject the notion that the prospect
of profits would encourage the inappropriate sale of ABXs [32,38,55,56,58] and oppose any
such separation [49,53,56].
Similar to some physicians [21] and pharmacists [23], a limited number of veterinarians
maintain that the generation of ABX resistance is the responsibility of other professional
groups, whether involved in human medicine or other veterinary sectors. Although a few
professionals even question the contention that ABX use in animals could pose a real threat
to human health [54,55], most veterinarians showed a high level of awareness and admitted
to being extremely concerned about the spread of resistance [26,34,36,55]. Efforts must
continue to be made to raise awareness among professionals in the sector [48,49,54,56].
Some veterinarians believe that a 50% reduction in ABX use on farms is feasible [38,40].
However, to achieve this, a close collaboration between veterinarians and customers [40],
and adequate communication skills are both fundamental [38,48].
3.3. Client-Related Factors
Many veterinarians identified a strong customer demand for ABXs as a factor that
could influence their treatment decisions. This is similar to factors identified as determi-
nants in human medicine [21], and is closely related to customers’ lack of knowledge and
indifference to the misuse of ABXs and spread of resistance. These results, obtained in
human and animal health, reflect the need to enhance the general population’s education
and awareness regarding ABX use, which would bring benefits across the sector [32,37–39].
In fact, many veterinarians in Europe stressed that customer awareness had improved in
recent years [48], which indicates that the educational interventions for the general popula-
tion that are being carried out could be yielding results [30,38,56], as has also been seen in
human health. Little evidence has been found of similar shifts in public sentiment towards
a more careful antibiotic use in developing countries, so public educational interventions
could be helpful in these settings [50].
At present, and especially in high income-countries, there is a growing consumer
pressure to reduce ABX use on farms. Although this might serve to reduce farmer requests
for antibiotics, there is a danger of creating demand for animals being raised without any
antibiotics at all, which can lead to a negative animal health and welfare outcome [49,54].
3.4. Structural and Concurrent Factors
Of the different interventions to reduce ABX use, those aimed at improving biosafety
and hygiene were pinpointed as some of the most important [30,32,34,36–38,40,41,53,55,56].
These measures are indispensable for reducing the consumption of antibiotics, as has been
shown by several field studies [67–69]. It should not be forgotten, however, that in an
industry where the profit margins are very narrow, many of these interventions are very
expensive [53], thus leading to the proposal that economic incentives should be provided
to enable farmers to apply them [50].
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With respect to the approach adopted by antibiotic policies, two perspectives are
to be found: (1) Endeavoring to improve ABX use through voluntary initiatives and
programmes promoting responsible ABX use [32,40,48], or alternatively, (2) opting for
more interventionist policies, as in Scandinavian countries [30,34,50]. Some countries also
use a mix: Voluntary initiatives promoting responsible use with government support and
some policy changes in areas where needed.
Despite the good results obtained in Sweden and Denmark in terms of reducing ABX
use in animals [13], it is difficult to ascertain whether this is a direct consequence of their
more tightly controlled ABX policies, e.g., Denmark’s introduction of ABX-use thresholds
for farms and fines for exceeding these [26,70]. Furthermore, the data furnished by other
countries, such as the United Kingdom, Germany or Belgium, with their promotion and
awareness-raising policies, are also good [32]. In general, veterinarians display reticence
towards these more restrictive policies, since they perceive them as a loss of professional
autonomy [33,55] and fear the possibility of being unfairly fined [31,37,47].
Regardless of the debate about the degree of intervention by the authorities, leg-
islative measures should foster prudent ABX use in all sectors (human, animal, and en-
vironmental) [34]. Many veterinarians are in favor of reinforcing the regulatory frame-
work [50,51,54,58]. There are many measures that can be sponsored by health and gov-
ernment institutions, e.g., strengthening infectious-disease surveillance systems [38,41],
providing databases on ABX resistance at a local and national level [36], restricting the sale
of ABXs without a previous formal veterinary consultation [58], prescription monitoring
with indicators and feedback to veterinarians [34,50], implementing electronic prescrip-
tion [33], introducing comparative prescription-evaluation systems [38,41], limiting the
prescription of certain ABXs [49], etc. All this poses a challenge for the authorities, and an
effort should therefore be made to ensure that any regulations which are introduced are not
perceived by professionals as merely disciplinary [33]. The authorities should recognize
the enormous effort made by the sector over recent years in many regions, which has led
to a drastic reduction in the use of antibiotics, and support veterinarians in such a way that
they can continue leading this task.
In some studies, professionals complained that the lack of time available for care
and the lack of veterinarians might lead to misprescription. Even though we know that
veterinary practices are private businesses with generally low margins in a competitive
business environment, minimum times for proper health care management could be
standardized and respected [57].
In many cases, pharmaceutical companies not only constitute one of the data sources
for veterinarians [43,47], but also dictate existing ABX product lines [47,49]. The role of the
industry in developing countries has proved more conflictive, since there have been reports
that, in certain settings, companies sold and advertised their products directly to farmers
without prescription or veterinary advice [50]. Of the selected studies, only five were set in
the context of low to middle-income countries. The situation in these countries with regard
to the use of ABX in comparison to that of countries in Europe and North America and
Australia and New Zealand (in which the rest of the studies took place) is very different. In
these five studies, as in different international reports [71], great concern is shown for the
inappropriate use of antibiotics in these regions, with lack of access to laboratory tests [50],
poor training [37], negligible awareness [51], absence of regulation [37], selling antibiotics
directly to consumers without prescription, etc. Accordingly, in such countries, where an
important part of worldwide animal production is concentrated [9], interventions targeted
both at enhancing awareness and training, and at strengthening the regulatory framework
are especially necessary [37,50,51].
3.5. Culture and Antibiogram Test
One of the recommendations and guidelines for rational ABX use in animals is to
confirm the diagnoses with the aid of culture and antibiogram tests. Although some EU
countries have now made the use of AST before using CIA’s obligatory, a number of
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studies show that the use of these laboratory tests as a decision-making support tool is not
as widespread among professionals as it should be [36,42,44,48,51]. Some veterinarians
admit that they only resort to them in the event of recurrent infections or treatment
failure [32,51], and we have noted in the studies that the cost and waiting time involved
in obtaining results are the main reasons for their use being limited. In addition, the
difficulty of justifying their use to clients must be added, when the latter demand the
fastest and cheapest solution possible [57]. Hence, the development of cheaper, faster, and
more reliable tests might increase their use and decrease the misuse of ABXs [33,39,53,56].
Furthermore, veterinarians’ and livestock farmers’ awareness of the importance of such
tests need to be enhanced, and health authorities could assess the desirability of subsidizing
their cost, wholly or in part [51].
3.6. Antibiotic-Related Factors
Some characteristics of ABX pharmacokinetics (route of administration, duration
of ABX activity, and time of elimination) are influential when it comes to choosing the
treatment, and are closely related with two other factors, namely, the skill of the farmer or
owner in applying the indicated treatment and the animal’s co-operation. This has led many
veterinarians to prefer injectable formulations with long-acting antibiotic preparations as
a means of ensuring therapeutic compliance: An example of this would be cefovecin. If
the appropriate antibiotic is not available for each animal and for each pathology with an
easily applicable route of administration, other, less suitable, antibiotics may be employed,
increasing the risk of generating resistance. The problem is that the WHO and OIE regard
cefovecin and other antimicrobials, as critically important for human and animal health,
and recommend that their use should be restricted [17]. This highlights how the lack
of availability of given antibiotics or certain presentations can cause other ABXs to be
prescribed, in the knowledge that they are not the best medicines indicated [47,51,55].
Work should be done to develop new pharmacological presentations that would enable
veterinarians to treat all the animals on the principle of antimicrobial stewardship, e.g.,
injectable long-acting formulations of antibiotics of lower importance, with an effective
duration of action of a few days [51,58].
Another important factor for veterinarians working in the food sector is the with-
drawal period. This is due, among other reasons, to the fact that the use of drugs with a
short withdrawal period in animals reduces costs, since the relevant animal-based prod-
uct(s) can be brought onto the market that much sooner. Hence, health authorities should
try to take into account this limitation when drawing up prudent ABX prescription proto-
cols, and envisage more than one alternative treatment for each situation, although we are
aware that the alternatives are very limited by the available and effective antibiotics for
each species in each country [51,53].
3.7. Animal-Related Factors
Several European studies reported that some veterinarians believed that livestock in
intensive production systems had poor immunity. It is important to monitor the health
of the herd [36] and also to ensure the quality of the animal feed [38,41] and promote
vaccination [30,32,37,53,55].
3.8. Alternative Treatments
Some veterinary conditions where antibiotics are often applied could be managed
solely with non-antibiotic treatments, such as surgical drainage and non-steroidal anti-
inflammatory drugs for abscesses treatments [38,41]. While many veterinarians are in favor
of these [31], many others are skeptical about their efficacy and clients’ ability to apply
them [52]. Therefore, it is important to invest in their promotion and in more clinical trial
evidence to convince both veterinarians and animal owners that outcomes are equivalent
without antibiotics [30,52].
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It should be noted that all the interventions proposed are useful for trying to min-
imize the influence which many of the factors identified in this review can exert on the
decision to prescribe, and thus it is essential that all sectors implicated co-operate fully in
their implementation.
3.9. Limitations
The main limitation of this review lies in that we included studies embedded in both
the companion and animal-production settings, although fully aware that they are very
different sectors.
It should also be mentioned that even though the regulatory framework is very
different across countries, we have not differentiated between the results achieved by the
geographical area (country). Along this line, almost all (reviewed) studies are European-
based, where the use of antibiotics is highly controlled, with almost no studies found in
developing countries, where a substantial fraction of ABX usage in animal production is
concentrated. Furthermore, the studies’ results have not been interpreted according to the
date in which the data were collected, although it is well known that the legal framework
and restrictions have changed considerably in recent years.
When interpreting the results, we must also take into account the methodological
heterogeneity of the studies selected, particularly in terms of data analysis, scales used, and
the fact that not all the studies focused on the analysis of the same variables. Furthermore,
the results have been collected according to the number of studies in which each factor is
mentioned, although there are significant variations between the number of veterinarians
participating in each study. Consequently, the results of this review should be interpreted
with caution. In our understanding, the abovementioned heterogeneity in methods, results,
and measurements precludes us from the possibility of performing a meta-analysis.
All things considered, we maintain that these limitations in no way alter the main
conclusions reached. There is a great consistency found in the results in different settings.
In addition, they are analogous to those obtained in physicians [21,22] and pharmacists [23].
Identifying these factors is an essential step to optimize the prescription of antibiotics
in animal settings.
Finally, we consider that the relationship between the identified factors and the
prescription of ABXs will have to be further detailed in the future by quantitative observa-
tional studies. Therefore, making the development of validated and reliable instruments
(e.g., questionnaires) indispensable to obtain results with a higher degree of evidence.
4. Materials and Methods
This study was conducted in accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The standards of the study
were ensured with the aid of the PRISMA 2009 checklist (Table S1), PROSPERO registration
number: CRD42020189747.
4.1. Search Strategy
To achieve the designated goals of this systematic review, a search was made in the
Medline, Web of Knowledge and Commonwealth Agricultural Bureaux (CAB) Abstracts
databases, covering an unlimited time period until March 2020, and using the following
search terms: (Veterinarian OR veterinary) AND (antibiotic* OR antimicrobial*) AND
(factor* OR attitude* OR knowle* OR percept* OR perceiv* OR belief*) AND (use OR
misuse OR overuse OR practice* OR prescription).
4.2. Inclusion and Exclusion Criteria
The papers included were required to meet the following inclusion criteria: Studies
were published in English or Spanish, and designed to examine factors and attitudes
associated with ABX prescribed by veterinarians, regardless of the sector in which they
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carry out their activity (pets, horse industry, animal production). The studies included
used both quantitative and qualitative methodologies.
4.3. Quality Assessment
When it came to evaluating the suitability of the studies selected, the two following
tools were used to assess the quality and susceptibility to bias: In the case of qualitative
studies, the Critical Appraisal Skills Programme (CASP) tool [25], and in the case of
quantitative and mixed studies, the critical appraisal tool to assess the quality of cross-
sectional studies (AXIS) [24]. An important aspect of these tools is that they evaluate
whether the conclusions reported by the studies are both credible and consistent with
respect to their stated objectives, methods, analysis, and results.
4.4. Data-Extraction and -Analysis
All data were extracted from the selected studies, bearing in mind the methodological
nature of the original study. Two of the authors (MS-D and M.T-T) reviewed the studies
separately, with any disagreements being settled by consensus.
A first table (see Table 1) was drawn up to summarize the methodological characteris-
tics of the papers selected.
Each of the studies selected was examined to identify the factors and attitudes that might
influence veterinarians when it came to prescribing antibiotics. To attain the review’s stated
goal, data were not collected on factors relating to clinical issues (e.g., clinical signs manifested
by the sick animal) or the results of complementary tests likely to be performed on animals
susceptible to diseases of infectious origin (e.g., imaging tests, laboratory results, etc.).
To facilitate the interpretation of results, factors identified as determinants were divided
into two categories, namely, factors intrinsic and extrinsic to the veterinary professional.
The intrinsic factors were, in turn, subdivided into two blocks, i.e., socio-demographic
characteristics and attitudes. The socio-demographic characteristics analyzed in the studies
were age, gender, years of experience, professional status, and professional training.
To ensure the correct allocation, prior to extracting the data, and based on the results
of similar studies undertaken by our group [22,23], a series of attitudes were predefined
as potential influences when veterinarians came to decide whether or not to prescribe an
antibiotic. These were:
• Complacency (with client expectations): The attitude that causes antibiotics to be
prescribed in order to meet what veterinarians perceive as their clients’ expectations.
• Fear: The attitude that reflects the fear felt by veterinarians at the prospect of the
future medical complications which an animal might suffer (Fear 1) or of the loss of a
customer (Fear 2), as a consequence of not prescribing an antibiotic at a given point
in time.
• Responsibility of others: The attitude which reflects the belief held by veterinarians
that the responsibility for the generation of antibiotic resistance in the community is
attributable to other professional groups.
• Self-confidence: The level of confidence felt by practitioners when it comes to prescrib-
ing an antibiotic, backed by their own habits and previous experience.
• Business factors: The set of attitudes that reflects the tendency to prioritize financial
and/or business factors when it comes to prescribing an antibiotic.
• Indifference: The absence of motivation to perceive, positively or negatively, the
problems associated with the misuse of antibiotics and, by extension, with antibi-
otic resistance.
• Ignorance: The treatment prescribed by the veterinarians does not match the current
knowledge and recommendations for treating the problem in question. Therefore, it is
a reflection of the veterinarians’ lack of proper knowledge.
Lastly, factors extrinsic to the veterinarian were analyzed and grouped into four categories:
• Customer-related factors (farmer or animal owner).
• Structural and concurrent factors.
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• Antibiotic-related factors.
• Animal-related factors.
For the purpose of evaluating the relationship between the above-mentioned factors
and the antibiotics prescribed in papers that furnished the quantitative results, the following
terms were defined:
• Statistically significant relationship: In the studies reviewed, the presence of this
factor increased the ABXs prescribing by veterinarians. This was deemed statistically
significant when the measure of association reported in the primary study was higher
than 1 and was associated with a p-value ≤0.05. This was denoted in the tables as (↑).
• Statistically significant inverse relationship: In the studies reviewed, the presence of
this factor decreased the ABXs prescribing. This was deemed statistically significant
when the measure of the association reported in the primary study was lower than
1 and was associated with a p-value ≤0.05. This was denoted in the tables as (↓).
• No significant relationship: In the studies reviewed, the presence of this factor had no
influence on the ABXs prescribing. This was deemed to happen when the measure of
the association reported in the primary study was associated with a p-value > 0.05,
which was not statistically significant. This was denoted in the tables as ( 6=).
• No symbol: In the study reviewed, the factor indicated was related with the ABXs
prescribing, but this relationship was not evaluated by statistical hypothesis testing.
5. Conclusions
As part of the overall strategy for reducing the spread of antibiotic-resistant bacterial
strains worldwide, the excessive and inappropriate use of antibiotics must also be reduced
in animals, and in this respect, veterinarians are a key element. Our results suggest
non-clinical factors which are associated with veterinary antibiotic prescribing (e.g., self-
confidence, biosafety deficits, fear, lack of awareness, inappropriate policies, etc.). These
are potentially modifiable, and could thus be the target of future interventions designed to
optimize ABX use in this sector, and decrease the prevalence of resistant bacteria in animals
and human beings alike.
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